Publications
(2000-2013):
1.
EL-Ahwany E., Hanallah S.,
EL-Ghorab M., Badir B., Badawy A., Sharmy R., Hassanein H. (2000).
Immunologicalization of macrophage adhesion molecule1 and macrophage
inflammatory protein-1 in schistosomal soluble egg antigen induced
granulomatous hyporesponsiveness. Int. J. Parasitol. 3:837-842.
2.
Kamel G., Metwally A.,
Guirguis F., Nessim N., Nosseir M. (2000). Effect of combination of the new
antischistosomal drug Ro 15-5458 and praziquantel on different strains of Schistosoma
mansoni infected mice. Arzneimittel-Forschung/Drug Research. 50:
391-394.
3.
Abdel Hadi A.M. and Talaat
M. (2000). Histological assessment of tissue repair after treatment of
human schistosomiasis. Acta Tropica, 77: 91-96.
4.
Maklad Y.A. and Nosseir
M.M. (2000). Androgenic and anabolic activities of some newly synthesized
epiandrosterone and progesterone derivatives. Scientia Pharmazeutica (Sci.
Pharm.) 68, 141-157.
5. Saber M.A., Reda M.A., El Malatawy M.A., Sadek A., Abou
Shousha T. (2000). Immunohistochemical study of Ki-67 antigen for early
detection of esophageal metaplasia in gastro-esophageal reflux disease (GERD). Sci.
Med. J. ESCME. 12: 3.
6. Helmy A.H.,
Abou Shousha T., Magdi M., Sabri T. (2000). Appendicitis; Appendectomy and the value of endemic
parasitic infestation. Egypt
7. Abu Zekri N., Kamel L., Akl M., Sadek A., Morsy A., Bibawi
H., Aboushousha T., Mekkawy Y. (2000). Diagnostic accuracy of
hyaluronan, telopeptide, collagen type IV-7S and type III procollagen
amino-terminal peptide serum assays as non-invasive biomarkers of liver
fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Med. J. Cairo Univ.
68: 137-146.
8.
Nosseir M., Metwally A.,
Kamel G., Guirgis F., Nessim N. (2000): Evaluation of the effect of
RO15-5458 and combined anti-schistosomal drugs on different strains of Schistosoma
mansoni infected albino mice: Histopathological and parasitological study. Egypt
9.
Bekheet I.W., Issawy F.M.,
Nosseir M.M., El-Sherief N.H., Sadek A. (2000). Immunohistochemical and serological studies of basic fibroblast
growth factor in chronic liver diseases and hepatocellular carcinoma. Egypt
10. El-Defrawi I., Diab M., Moussa M., El-Ray A.,
El-Sherbini E. (2000): Rapid non-invasive diagnosis of Helicobacter
pylori in dyspeptic patients. Egypt
11. El Baz H.G.,Wishahi M.M., Hammam O.A. (2000):
Expression of P53 and C erb-B2 oncoprotein in chronic schistosomal urinary bladder lesions. Kasr El Aini .
Med. J. 6: 503-518.
12. Helmy A.H.I., Hammam O.A. (2000): Inflammatory response
in the fixation of proline mesh N buteyl 2cyanoacrylate (Histoacryle) in
abdominal wall: Experimental study. Egypt
13. Hammam O., Riad E., Akl M., Hindawi A., Abdel Hadi A., El
Sherif E. (2000): Clinical significance of DNA content analysis (ploidy)
and morphometric measurement in schistomal transitional cell carcinoma to
chronic schistosomal cystitis, Transitional cell papilloma G0 and normal
urothelium with its application in urine samples. Kasr El Aini Med. J. 6: 349-364.
14. Akl M.M., El-Hindawi A.F., Hammam O.A., Abou-Shousha T.,
El-Baz A.G., Abdel Hadi A.M., Badawy
A.A. (2001). Predictive value of Ki67 expression in schistosomal associated
bladder lesions versus non schistosomal ones in correlation to urothelial
ploidy and morphometric parameters. J. Eu. Soc. Pathol. 3: 393.
15. Hassan S.I., Nessim N.G., Mahmoud S.S., Nosseir M.M. (2001).
Effect of broad spectrum anti-parasitic drug “Ivermectin” in acute and chronic
experimental giardiasis using different dose regimens. J. Egypt. Soc.
Parasitol. 2: 419-430
16. William S., Sabra A., Ramzy F., Moussa M., Demerdash Z.,
Bennett J., Day T. and Botros S. (2001). Stability and reproductive fitness
of Schistosoma mansoni isolates with decreased sensitivity to
praziquantel. Int. J. Parasitol. 31: 1093-1100.
17. EL-Bassiouni N., EL-Sayed H., Lotfy M., Badawy A.A., Roshdy
M., Asaad S., Iskander J. (2001):
Modulation of ABH and Lewis antigen expression in cancer bladder associated
with schistosomiasis. Kasr EL-Aini
Med. J. 7: 201-215.
18. Rizk H.A., Abou Shousha T. (2001). The identification of
a novel Helicobacter species in cholecystitis specimens; A preliminary
study. Kasr El Aini J. Surg. 2: 19-23.
19. Rizk H., Reda
M.F., Ezzat H., Abou Shousha T., Nosseir M. (2001). The possible role of Helicobacter
like species in the aetiology of chronic cholecystitis in patients with
positive gastric Helicobacter infection. Kasr El Aini J. Surg. 2:
113-116.
20. Saber M., Ahmed H., Abu-Aitta A., El-Defrawi I., Saad El-Din
S., Moussa M., Shoman M., Mikhail N., Helmy A. (2001). Identification of Helicobacter
sp. in bile and resected gall bladder tissue from Egyptians with chronic
calcular cholecystitis. Az. J. Microbiol.
52: 107-116.
21. Abbas M., Youssef Y., Hazem A., Nafeh A., Moussa M., Naseem I. Egypt
22. Diab M., El-Serif N., Moussa M., Ahmed H., El-Assaly
N., El-Ghannam M., El-Ashry N., Akl M.
(2001). Autoimmunity in chronic liver disease: Clinical, serological and
immunohistochemical correlations. Egypt
23. Demerdash Z., Moussa M., El-Baz H., Salah F., El-Baz
A., Akl M. (2001). Tissue
localization of Schistosoma haematobium antigens and expression of p53
and cytokeratin18 in different urinary bladder lesions. Kasr El-Aini Med. J.
7: 355-375.
24. Essawy M.M., El-Bee A., Ezzat H., Abbas M., El-Batanouny
M., Nosseir M.M., Omran Z.S., Khaled
I.A. (2001). Effect of splenectomy
on liver fibrogenicity in portal hypertension patients. Egypt
25. El Ray A., Fam N., Aboul Fadl L., Hammam O., Ahmad H Akl M.,
El Sherbini., Saber H. (2001). Monitoring of successful eradication of Helicobacter
pylori by endoscopic, serologic, molecular and histopathological methods
in Egyptian dyspeptic patient. Kasr El Aini. Med. J. 7: 195-221.
26. Saber M.A., Sherief S.A. June
27th – 29th 2001 , Palestine Hotel, Alexandria , Egypt
27. El Baz H.G., Hammam O.A., Hanallah S.B., El Baz A.G., Giguis
B.M., Guafar T. (2001). Vascular endothelial growth factor: An important
angiogenic mediator in chronic bladder lesions.
Kasr El Aini. Med. J. 7: 29-47.
28. Mahmoud S., Demerdash Z., Mohamed S., Badawy A.A., Mohamed
S., Shaker Z., Ibrahim A. (2002). Study of kinetics of circulating
schistosome antigens in tissues and sera of infected mice using anti-Schistosoma
mansoni soluble egg antigen monoclonal antibody. Egypt
29. Salah F., Hassanein H., Hassan S., Sayed S., Badawy A.
(2002). The dynamics of serum and hepatic schistosomal antigens in two
different strains of mice. Egypt
30. Mahmoud M.R., Zohairy M.K., Nosseir M.M.F. (2002). Effect
of combined chemotherapy and anti-inflammatory drugs on murine schistosomiasis. Arzneimittel-Forschung/Drug Research 52:
294-301.
31. Badawy A.A.,
Hammam O.A. (2002): E-cadherin
and epithelial membrane antigen expression in schistosomal urinary bladder
lesions. J. Egypt. Soc. Path. 22:283-290.
32. El-Wakil H.S., Aboushousha T.S., El-Haddad O., Gamil N.B., Mansour T., El-Said H. (2002).
Effect of Schistosoma mansoni egg deposition on multiple low doses
streptozotocin induced insulin dependent diabetes. J. Egypt. Soc. Parasitol.
32: 987-1002.
33. Abou Shousha T., Moussa M., El-Khayat H., Yehia H., Seif S.
(2002). Expression of Ki-67 and human Papilloma virus in
premalignant and malignant eosophageal lesions. J. Egypt
34. Mahmoud F., Moussa M., Mahmoud S. (2002).
Detection of Schistosoma haematobium antigens in serum and urinary tract
tissue of infected hamsters using specific monoclonal antibody. Kasr El-Aini
Med. J. 8: 51-66.
35. Hanallah S., Mahmoud S., Moussa M., Botros S. (2002).
Altered immunoglobulin isotype profile and anti-immature worm surface
immunoglibulins G & M in mice harboring a praziquantel resistant Schistosoma
mansoni isolate. Kasr El-Aini
Med. J. 8: 265-281.
36. Nessim I., Abu Zikri N., Moussa M., Hafez T., Hazem
A., Reda M., Abdel-Hadi A., Edward N., El-Ghafir W. (2002). Implication of
tumor necrosis factor alpha (TNF-α),
interleukin beta (IL-1ß) and intercellular adhesion molecule-1 (ICAM-1) in warm
hepatic ischaemia reperfusion injury: Effect of intraportal infusion of
prostaglandin E1. Egypt
37. Moussa M., Hammam O., Hassan E., Turky E., Seif S., Youssef
M. (2002). Study of immune response and apoptosis in Helicobacter pylori-associated
gastric lesions. J. Egypt. Soc. Path. 22: 301-309.
38. Bekheet I., Zahran N., Nosseir M., Ibrahim A., Wilson M.,
Mostafa I., Essawy F. (2002).
Clinical significance of angiogenic and fibrinolytic factors in chronic liver
disease and hepatocellular carcinoma. Egypt
39. Akl M.M., Hammam O.A., El Baz H.G., Demerdash Z.A.,
Sadek A., Mostafa I. (2002).
Expression of intercellular adhesion molecules ICAM-1 and cytokeratin as
potential markers of disease activity in the Egyptian pattern of chronic
hepatitis C. Med. J. Cairo Univ.
40. Badawi H., Ahmed H., Diab M.S., Aboul Fadl L., Helmi A., El-Khafif N.,
Omran Z., Tosson W., Akl M., Saber M.A. (2002). Role of Cytomegalovirus (CMV) and
Epstein-Barr Virus (EBV) in urinary bladder cancer: Microbiological, molecular,
pathological and electron microscopic characterization. Egypt
41. Abdel Hadi A.A., Desouky A.M., El Damrawi M., Hammam O.A.,
Sadek A., Abdel Hadi A. (2002).
Th1/Th2 serum cytokines imbalance and their relevance to severity of disease in
HCV-related liver cirrhosis. Egypt
42. Hammam O.A., Tosson
W., Kamel A.I., Moustafa
A., Mehena A.A., Hady A.A. (2002). Prognostic significance of tumor
angiogenesis in superficial bladder tumors. Egypt
43. Botros S., William S., Hammam O., Zidek Z., Holy A. (2003).
Activity of 9-(S)-{3-hydroxy-2-(phosphonomethoxy) propyl} adenine against
schistosomiasis mansoni in mice. Antimicrobial Agents and
Chemotherapy. 3853-3858.
44. Abou Shousha T.S., Yehia H.A., Badawy A.A. (2003). Focal
hepatic lesions; cytopathological and clinico-ultrasonographic survey in
endemic locality. Kasr El- Aini Med. J.
9: 57-68.
45. El-Assaly N., El-Ray A., Abou Shousha T. (2003).
Clinical, sonographic, biochemical and histopathological assessment of hepatic
steatosis in Egyptian patients with HCV and HCV associated HCC Kasr El-Aini
Med. J. 9: 191-207.
46. Badawi H., Ahmed H., Ismail A., El-Khafif N., Helmy A.,
Badawy A.A., Mansy S., Saber M.A. (2003). Role of human papillomavirus 16
in urinary bladder cancer: New approach for detection of antiviral IgG in
correlation to detection of the virus by electron microscopy or viral DNA by
PCR. Egypt
47. Zakaria S., Akl M., Nosseir M., Amer A., Anwar H., and
Abu-Madian M. (2003). Clinico-pathologic profile of non-alcoholic hepatic
steatosis in Egypt .
Proceedings of the XIV Annual Congress of ESLM. pp. 1-18.
48. Abbas M., Omran Z., Nosseir M. (2003). Histopathological
assessment of the effect of non-absorbable prosthetic mesh on the spermatic
cord contents: An experimental study. Egypt
49. Zoheiry M.K., Nosseir M.M., El-Ahwany I.G. (2003).
Down-regulation of intercellular adhesion molecule-1 (ICAM-1) and lymphocyte
funtion-associated antigen-1 (LFA-1) on chronic hepatic murine schistosomiasis mansoni.
Kasr El-Aini Med. 9: 99-116.
50. Saber M.A., Abou Shousha T.S., Ahmed M.H., Romeih M.H., Sadek
A, Abdel Hady A.M. (2003).
Reliability of histopathological and molecular techniques for diagnosis
of hepatitis B and C viruses in chronic liver diseases. Kasr El Aini Med.
J. 9: 123-140.
51. El-Lakkany
N.M.
52. Badawy A.A., El-Hindawy A.A., Khattab H.M., Abo-Shousha T.S,
El-Shahat N.S., Omran Z.S. (2004). Significance of P21 and C-myc expression
in bladder urothelial lesions. J. Egypt. Soc. Path. 23: 277-284.
53. Moussa M., Nosseir M., Omran Z., Guirguis N., Yehia H.,
El-Khayat H., Siam M., Yousef M. (2004). Occurrence of gastro duodenal
giardiasis and/or Helicobacter pylori infection after gastric acid
suppression. Egypt
54. Badawy A.A., Nosseir M.M., Moussa M.M. (2004).
Immunoreactivity of p53 and Ki-67 in some chronic urinary bladder lesions. Kasr
El-Aini Med. J. 10: 85-94.
55. Seif El-Din S.H., El-Lakkany
N.M.
56. Akl M., Zakaraia S., El-Hindawi A., Hammam O., Yehia H.,
El-Raziky M., Ibrahim R., Fakhry S., El-Behairy N. (2004). Impact of
apoptosis on the severity of chronic hepatitis C in a sample of Egyptian
patients. J. Egypt
57.
Abou El Eila G.M.,
Barsoum H.B., Omran Z., Kamar S.A. Egypt
58. Akl M.M., Hammam O.A., Hassanein M., El Ghannam M., Abou
Shousha T.S., El Ray A., Kishta S.A.
59. El-Shazly S.H., Hammam O.A., Abdel Salam M., El-Hady A.M.
(2004). Immunohistochemical detection of Fas expression and Bcl2 in liver
tissues of patients with chronic liver diseases. Sci. J. Az. Med. Fac.
(Girls) 25: 831-848.
60. Hassan S.I., Ali I., Nessim N.G., Amer N.M., Nosseir M.,
El-Khafif M.A., Ashour A., El-Mohandes M. (2004). Egg excretory
pattern with respect to hepatic collagen content in chronic Schistosoma
mansoni-infected mice given praziquantel and an anti-fibrotic. Kasr
El-Aini Med. J. 10: 33-40.
61. Romeih M.H, Hanem M.A., Abou Shousha T.S., Saber M.A. (2005).
Vaccination against Schistosoma mansoni infection by DNA encoding
SM 21.7 antigen. Nature
and Science. 3: 28-35.
62. Akl M., Zakaria S., El-Hindawi A., Hammam O., Yehia H., El
Raziky M., Ibrahim R., Fakhry S., El Behairy N. (2005). Impact of apoptosis
on the severity of chronic hepatitis C. Virchows Archiv. 447: 297.
63. Badawy A., Hammam O.
(2005). Hepatic expression
of endothelial nitric oxide synthase (ENOS) and vascular endothelial growth
factor (VEGF) in chronic hepatitis C and schistosomal liver disease. Virchows
Archiv. 447: 298.
64. Badawy A.,
EL-Hindawy A., Khattab H., Abo-Shousha T., El-Shahat N., Omran Z. (2005). Significance of P21 and C-myc expression in
bladder urothelial lesions. Virchows Archiv. 447: 347-348.
65. Badawy A., Nosseir
M., Moussa M. (2005).
Prevalence of p53 and Ki-67 immunoreactivity in chronic urinary bladder
lesions. Virchows Archiv. 447: 355.
66. Badawy A., Hammam O.
(2005). E-cadherin and
epithelial membrane antigen expression in schistosomal urinary bladder lesions.
Virchows Archiv. 447: 355.
67. Akl M., Zakaria S., Hammam O., El Raziky M., Yehia H., Fakhry S., Seyma M., Ibrahim R., El-Hindawi A.,
El Behairy N. (2005). Hepatocyte apoptosis in chronic hepatitis C: A
prominent feature of disease severity in Egyptian patients. Virchows Archiv.
447: 300-301.
68. Hazem A.I., Abdel-Hady A.A.,
El-Shanawany F., Hammam O., Abdel-Hady A.M. (2005). The pharmacological approach to reverse portal
hypertention and hepatic schistosomal fibrosis in Egypt : Control experimental study. J.
Egypt. Soc. Parasitol. 35: 731-750.
69. Zakaria S., Akl M., Nosseir M., El Raziky M., Amer A., Anwar
H., Abu-Madian A. (2005). Hepatic steatosis in Egypt . A clinical and pathological
profile. Virchows Archiv. 447: 301-302.
70. Zakaria S., Akl M., Nosseir M., El-Serafy M., Abul-Ezz M.
(2005). The use of argon plasma coagulation (APC) in portal hypertensive
gastropathy (PHG). Accepted for publication in World Journal of
Gastroenterology (WJG) on (28-2- 2005). Printed in China
71. Mahmoud M., Ebeid F., Nosseir M. (2005): Enhanced role of grapefruit juice on the
anti-schistosomal activity of artemether on the liver of Schistosoma
haematobium infected hamsters. Scientia Pharmazeutica (Sci. Pharm.)
Under press (2005).
72. Saleh S., Mahmoud M., El-Abhar H., Omran Z. (2005).
Anti-schistosomal effect of thymoquinone in murine schistosomiasis mansoni:
Influence on nitric oxide, ICAM-1 and collagen. Kasr El-Aini Med. J.
11: 117-127.
73. El Mohandes M.Y., Omran Z., El Khayat H.R. (2005). High grade of hepatitis C virus activity is
associated with up-regulation of circulating interleukin-10 level. Kasr
El-Aini Med. J. 11: 155-161.
74. Akl M., Nosseir M. Badawy A.A., El-Baz A., Roshdy M., El-Leithy T. (2005). Histopathologic
assessment of angiogenic response in different urinary bladder lesions. Proceedings
of the XVI Annual Congress of ESLM, March 2005.
75. El-Khafif N., Yehia H., Hammam O., Mahmoud S., Helmy A.,
Boehm S., Voss B., Mansy S., Akl M., El Fandy G. (2005). Ultrastructural
hepatic changes after bone marrow transplantation in murine schistosomiasis. Kasr
El Aini Med. J. (Under press) 2005.
76. Zakaria S., Akl M., Hammam O., El Raziky M., Fakhry S., Seyam
M., Yehia H., Ibrahim R., El Hindawi A., El Behairy N. (2005). Hepatocyte
apoptosis in chronic hepatitis C: A prominent feature of disease severity in
Egyptian patients. J. Hepatol. Gasteroenterol. Infect. Dis. 10: 31-44.
77. Akl M.M., Hammam O.A., Helmy A.H.I., Mahgoub M.A., Ammar A.,
Ashmawi H.A.A. (2005). The sub-deltoid versus intra-peritoneal implantation
of canine macro-capsule allogenic amniotic membrane; assessment of rejection
and neo-vascularization. Egypt
78. Hassan S.I., Ali I., Nessim N.G., Amer N.M., Nosseir M.,
El-Khafif M.A., Ashour A., El-Mohandes M. (2005). Transmission hepatic
electron microscopic findings in acute experimental schistosomiasis mansoni
after praziquantel and an anti-fibrotic. Kasr El-Aini Med. J., 11:
23-28.
79. Ebeid F., El-Lakkany N, El-Deen S.S., Sabra A., Nosseir M.,
Botros S. (2005). Effect of mirazid against different developmental
stages of Schistosoma mansoni worms and its safety in normal mice. Egypt
80. Hammam O., Roshdy M., Abou Shousha T., Aziz A. (2006). Possible role of cyclooxygenase-2 in Schistosoma-and
non-Schistosoma associated bladder cancer. Kasr El Aini Med. J. 12:
99-108.
81. Omar M., Fam N., Saad El-Din S., Romeih M., Mohamed H.,
Hassan M., Mostafa I.
82. El-Ahwany E., Nosseir M.M., Aly I.R. (2006).
Immunomodulation of pulmonary and hepatic granulomatous response in mice
immunized with purified lung-stage schistosomulae antigen. J. Egypt. Soc.
Parasitol. 1: 335-350.
83. El-Bassiouny A., Nosseir M., Zoheiry M., El-Ahwany E., Ghali
A., El-Bassiouni N. (2006). Immunohistochemical expression of CD95
(Fas), C-myc, and epidermal growth factor receptor in hepatitis C virus
infection, cirrhotic liver disease and hepatocellular carcinoma. Acta Pathol, Microbiol Immunol
Scandinavica (APMIS) 114: 420-427.
84. El Bassiouny A., El Ahwany E., Abou Shousha T., Moussa M., El
Bassiouni N., Maher K., Galli A., Youssef M., Suher Z. (2006). Hepatic mRNA expression of histone (H3): An
early predictor of tumorgenic changes in chronic hepatitis C. J
Gastroenterol. Hepatol. 21, (Suppl. 2), Abstract ≠ 297, p A164. *
Accepted at Shanghai–Hong Kong
International Liver Congress "Drug Discovery for the Treatment of Liver
Diseases” , Shanghai , China
85. Botros S., Mahmoud M., Hammam O., Salah
F., Zidek Z., Masek K. (2006). Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel
in mice infected with different S. mansoni isolates. Acta.
Pathol. Microbiol. Immunol. Scandinavica (APMIS). 114: 480-491.
86. Helmy A., Hammam O., El Leithy T., Wishahi M. (2007).
The role of TGF-beta-1 protein and
TGF-beta-R-1 receptor in immune escape mechanism in bladder cancer.
Medscape-General-Medicine (MedGenMed) 9:34.
87. El-Lakkany N.,
Nosseir M. (2007). Pharmacodynamics
of pentoxifylline and/or praziquantel in
murine schistosomiasis mansoni. Acta. Pathol. Microbiol. Immunol. Scandinavica (APMIS) 115: 184-194.
88. El-Bassiouny A.,
Zoheiry M., Nosseir M., El-Ahwany E., Atta R. El-Bassiouni N. (2007).
Expression of cyclooxygenase-2 and trasforming growth factor-β1 in HCV-induced
chronic liver disease and hepatocellular carcinoma. MedGenMed; www.medscapegeneralmedicine.com US
89. Botros S.S., Mahmoud M.R., Moussa M.M., Nosseir M.M. (2007).
Immunohistopathological and biochemical changes in Schistosoma mansoni-infected
mice treated with artemether. J.
Infection. 55: 470-477.
90. Abbas M., Farouk
Y., Nafeh A., Nasr M., Nosseir M.,
Zoheiry M. (2007). Regenerative potential
of cirrhotic liver following selective extra-hepatic vascular ligation: An experimental
study. Kasr El-Aini J. Surg.
8: 75-84.
91. Kamel M., Maher
K., Nosseir M., El-Bassiouni N., El-Bassiouny A., Ghali A., (2007). Frequency of HLA-DRB1*alleles
in patients with hepatitis C virus infection: Relevance to clinical outcome.
Kasr El Aini Med. J. 13: 75-82.
92. Saber M.A., Diab
T., Nosseir M.M., Mohareb M.N., El-Dabaa E. (2007). DNA vaccination using Schistosoma
mansoni fimbrin gene on naive and infected praziquantel-treated mice. New Egypt. J. Med. 37: 24-34.
93. Nafeh A.I., Nosseir
M.M. (2007). Assessment
of peritoneal adhesions due to starch granules of surgical glove powder: An experimental
study. J. Egypt. Soc. Parasitol. 37: 835-842.
94. Sadek A, Abd El Hady A M, Hammam O, Elbasha H, Abd El Hady A
(2007). Effect of ozone gas with and without
anti-oxidants on viral kinetics and liver histopathology, in hepatitis C patients:
A phase II clinical study. Accepted for publication in World Journal
of Gastroenterology (WJG), on (9- 4- 2007).
95. Hafez T., Moussa M., Nesim I. ,
Baligh N., Davidson B., Abdul-Hadi A. (2007). The effect of intraportal prostaglandin E1 on adhesion molecule
expression, inflammatory modulator function, and histology in canine hepatic
ischemia/reperfusion injury. J. Surg. Res. 138: 88-99.
96. Essawy MM, Nafeh AI, Ezzat HM, Elsebae MM, Marei SA, Salama
AF, Badawy AA. (2007). The effect
of portal vein branch plus
heterochronous hepatic artery branch ligation on liver regeneration
(experimental study). J. Egypt. Soc. Parasitol. 37 (2): 557-570.
97. El Bassiouny A.,
Zoheiry M., El-Ahwany E., Salah F., Nosseir M., Omran Z., Atta R., El-Bassiouni N. (2008). Circulating and hepatic Fas expression in
HCV-induced chronic liver disease and hepatocellular carcinoma. Medscape J Med. www.medscapegeneralmedicine.com USA; 10 (6):130. ©2008 Medscape
98. Fahmy Z.H., Mohammed A.H., Nosseir M.M. (2008).
Ultrastructural and histopathological changes in Giardia Lamblia-infected
hamsters following administration of two natural compounds and/or metronidazole. New Egypt. J. Med. 38: 53-61.
99. Youssef F.Y.,
Nosseir M.M. (2008). Effect of increased intra-abdominal pressure
due to pneumoperitoneum on liver functions and liver histopathology in a rat model
with intra-abdominal sepsis. J. Egypt. Soc. Parasitol. 38: 161-170.
100. Badawy H., Ahmed H., Ismail A., Diab M., El-Din S.S., Nosseir
M.M., Omran Z., Saber M. (2008). Human Papilloma virus DNA
and p53 protein expression among Egyptian patients with urinary bladder cancer
in relation to schistosomiasis and clinico-pathologic outcome. Egyp. J. Med.
Microbiol. 17: 593- 603.
101. Hala Badawi, Hanem Ahmed, Ahmed Ismail, Amira Helmy, Afkar
Badawy, Manal Diab, Laila Abuel-Fadl and Aisha Abu-Aitta (2008). Diagnostic
performance of different assays for detection of Chlamydia trachomatisin
in patients with chronic cystitis and cancer bladder. Departments of Microbiology, Biochemistry, Urology, Electron
Microscopy and Pathology, Theodor Bilharz Research Institute. Research Journal of Medicine and Medical
Science; 3 (1): 1-13. http://www.insinet.net/jasr.html
102. Hala Badawi, Hanem Ahmed, Ahmed Ismail, Manal Diab, Magd
Moubarak, Afkar Badawy, Mohamed Saber
(2008). Role of human
papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder
cancer among Egyptian patients. Departments of Microbiology, Biochemistry, Urology and
Pathology, Theodor Bilharz Research Institute. Medscape J Med; 10 (10):232. http://www.medscape.com
103. Maisa Omar, Samah Saad
El-Din, Nevine Fam, Manal Diab, Mohamed Shemis, Manar Raafat, Moataz Seyam,
Moataz Hassan, Afkar Badawy, Maha Akl,
Mohamed Saber (2008): SEN virus infection in Egyptian chronic hepatitis C
and haemodialysis patients. Departments of Microbiology, Biochemistry,
Nephrology Gastroenterology and Hepatology and Pathology, Theodor Bilharz
Research Institute. Medscape J Med;
10 (12): 290. http://www.medscape.com
www.PubMedCentral.gov
104. Botros S., Hammam O., El-Lakkany N.M., Seif El-Din S.H.,
Ebeid F. (2008). Schistosoma haematobium (Egyptian strain): Rate of development and effect
of praziquantel treatment. J. Parasitol. 94: 386-394.
105. Hammam O., Aziz A., Roshdy M., Abdel Hadi A. (2008). Possible
role of cyclooxygenase-2 in schistosomal and non-schistosomal-associated bladder
cancer. Medscape. J. Med.
10 (3):60.
106. Hadi A., Hammam
O.A., Noh A. (2008). Histopathological changes and DNA pattern in esophageal
and gastric mucosa before and after treatment of esophageal and gastric varices.
Australian J. Basic Appl. Sci. (AJBAS). 2: 658-671.
107. Hassan E., Hegazy A., Moussa M., Abdel-Wahab N., Seif S.
(2008): Effect of garlic on tumor invasion and metastatic potential in induced
colon carcinogenesis in rats: Histopathological and immunohistochemical study. JASMR.
3: 11-19.
108. Diab M., El-Din S.S., Aboul-Fadl L., Moussa M., Omran Z.,
Shemis., El-Ghannam, M. El-Ray A.,
Badawi A., El-Defrawi I., El-Sherbini E., Saber M. (2008). Inducible nitric
oxide synthase expression in Helicobacter pylori CagA+ strains infections".
E. J. Micro. 17: 605-613.
109. Abbas M,
Farouk Y,
Nasr MM,
Elsebae MM,
Farag A,
Akl MM,
Hammam O
(2008). Gastrointestinal stromal tumors (GISTs): Clinical
presentation, diagnosis, surgical treatment and its outcome. Departments
of Surgery and Pathology, Theodor
Bilharz Research Institute. J
Egypt Soc Parasitol.; 38(3):883-94.
110. Bassiouny A, Abo El-Hassan S, Moussa M,
El-Ahwany E, Helal E, Taha A, Helmy AH, Kamel M and El-Bassiouni N (2009). Down-regulation
of intrahepatic CD16+ and CD56+ immune cells in chronic
hepatitis C virus infection and HCV-related hepatocellular carcinoma. Arch
Med Sci, 5 (3): 321-328.
111. Shaker OG, Hammam O, Saleh A, El Leithy T and
Wishahi M (2009).
Possible role of telomerase and sFas in pathogenesis of various bladder
lesions associated with schistosomiasis. Clinical Biochemistry Journal, 42 (9): 864-872.
112. Moussa M, Omran Z, Nosseir M, Lotfy A and
Swellam T (2009). Cyclooxygenase-2
expression on urothelial and inflammatory
cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder
carcinoma. Acta Pathol Microbio.
Immunol Scandinavica (APMIS), 117: 45-52.
113. Bekheet IW, Madkour ME, Abdel Ghaffar N, Nosseir MM,
Moussa MM, Ibraheim RA and Ateya ME (2009). The role of myeloperoxidase in hepatitis C virus infection and associated
liver cirrhosis. Open J Trop Med (Bentham) Bakistan, 2: 1-7.
114.
Elkhafif
N, Voss N, Hammam OA, Akl M, Boehm S, Yehia H, Mansy S, El Bendary O and El Fandy G (2009). Differentiation and homing of transplanted bone marrow
cells in livers of murine schistosomiasis. Australian Journal of Basic and Applied Science (AJBAS),
2(4): 1362-1372.
115. Akl MM,
Hammam OA, Mohamed HS, El Baz HG, Demerdash Z, Atta R and Shaker Z (2009). Localization
of Schistosoma mansoni antigen confirms the frequent coexistence of
hepatic schistosomiasis with chronic viral hepatitis C. An immuno-histochemical
study. Accepted for publication in Australian
Journal of Basic and Applied Science (AJBAS) at 4-1-2009.
116. El Bassiouny A, Ahwany E, Abou Shousha T,
Moussa M, El Bassiouni N, Maher K, Galli A, Youssef M, and Zada S (2009). Hepatic
mRNA Expression of Histone (H3): An Early Predictor of Tumorgenic Changes in
Chronic Hepatitis C. Arch Med
Sci, 5 (4): 1-7.
117. Atta HM, Al-Hendy A, Salama SA, Shaker OG and
Hammam OA (2009). Low-dose simultaneous delivery
of adenovirus encoding HGF and VEGF in dogs enhances liver
proliferation without systemic growth factor elevation. Liver International,
29 (7): 1022-1030.
118. Botros SS, El-Lakkany NM, Badawy AA, Mahmoud
SS, Ebeid FA and Fenwick A (2009). Mirazid shows insignificant activity against
ovine fascioliasis. Ann Trop Med Parasitol, 103 (7): 605-616.
119. Hammam O, El Ganzoury H, Abdel Hadi A and
Akl M (2009). Immunohistochemical Study of Caspase 3 and Cyclin D1 in
Bilharzial Bladder Cancer and Their Significance. Australian Journal of
Basic and Applied Science (AJBAS), 3 (2): 1198-1205.
120. Badawi H, Ahmed H, Aboul Fadl L, Moubarak
M, Helmy A, El-Khafif N, Ismail A, Badawy A, Omar M and Saber M (2009).
Performance of different cytomegalovirus diagnostic assays in bladder cancer
patients with schistosomiasis. Medscape Archives of Medical Sciences
Accepted on 19 May, 2009. www.archives of
medical science.com
121. Zakaria S, Youssef M, Moussa M, Akl M, El-Ahwany E,
El-Raziky M, Mostafa O, Helmy AH and El-Hindawi A (2010). Value of alpha-smooth muscle actin and glial fibrillary acidic
protein in predicting early hepatic fibrosis in chronic hepatitis C
virus-infection. Arch Med Sci, 5 (4): 1-7.
122. Badawi H, Ahmed H, Aboul Fadl L, Helmy A, Fam
N, Diab M, Ismail A, Badawy A and Saber M (2010). Herpes
simplex virus type-2 in Egyptian patients with bladder cancer or cystitis. Acta Pathologica Microbiologica et
Immunologica Scandanivica (APMIS), 118: 37-44.
123. El Ray A, Moucari R, El Ghannam M, Taha AA, Saber MA, Akl M, Asselah T, Atta R, Shemis M, Radwan AS, Ghali A and Paradis V (2010).
Insulin resistance: A major predictor of significant liver fibrosis in Egyptian
patients with genotype 4 chronic hepatitis C. Journal of Hepatology, 52:
409-409.
124. Ghanem L
Y, Dahmem U, Dirch O, Nosseir MM, Mahmoud SS and Mansour WA (2010).
Does granulocyte-colony stimulating
factor administration induce damage or repair response in schistosomiasis?. World
J Hepatol, 2 (12): 434-441.
125. Elkhafif
N, Voss B, Hammam O, Yehia H, Mansy S, Akl M, Boehm S, Mahmoud S, El Bendary O
and El Fandy G (2010). Homing of transplanted bone
marrow cells in livers of Schistosoma mansoni infected mice. Acta
Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 118
(4): 277.
126. Toima S, Saleh A, Madkour
M, Hammam O and Abd El-Raouf E (2010): Role of hepcidin in anemia of patients with chronic
hepatitis C. Journal of American Science, 6 (12):145-154.
127. Botros
SS, Hammam O, Mahmoud M and Bergquist R (2010). Praziquantel
efficacy in mice infected with PZQ non-susceptible S. mansoni isolate
treated with artemether: parasitological, biochemical and immunohisto-chemical
assessment. Acta Pathologica,
Microbiologica et Immunologica Scandinavica (APMIS), 118 (9): 692-702.
128. El-Baz HG, Kamel MM, Hammam OA
and El-Baz AG (2010): Potentials of Transforming Growth
Factors-Alpha and Beta-1 in Predicting the Clinical Outcome of Bladder
Carcinoma. International Journal of Immunological Studies (IJIS), 1(2): 169-
182.
129. Hammam O, Abdel Aziz I, Mahmoud O, Zahran M, Alkholy A, Abdel Hadi
A, Akl M, Wishahi M, Voss B and Boehm S (2010): Her 2/Neu gene and VEGF in bladder cancer in Egypt: Relationship
to schistosomiasis. Journal of American Science, 6 (12): 927-93.
130. Bassiouny AE, Nosseir
MM, Zoheiry MK, Ameen NA, Abdel Hadi AM, Ibrahim IM, Zada S, El Deen AH and El
Bassiouni NE (2010): Differential expression of cell cycle regulators in
HCV infection and related hepatocellular carcinoma. World J Hepatology, 27;
2 (1): 32-41.
131. El Bassiouny AE, El-Ahwany EG, Zoheiry MK, Nosseir MM, Ibrahim RA, Ibrahim IM, Zada SK and El-Bassiouni NE (2011). Circulating bone
marrow derived fibrocytes contribute to the expression of myofibroblast pool in
HCV-mediated liver fibrosis. Journal of Hepatology, 54: 131-132.
132. Elkhafif N, El Baz H, Hammam O, Hassan S, Salah F, Mansour W, Mansy S, Yehia H, Zaki A, Magdy R (2011): CD133
(+) human umbilical cord blood stem cells enhance angiogenesis in experimental
chronic hepatic fibrosis. Acta Pathologica, Microbiologica et Immunologica
Scandinavica (APMIS), 119 (1): 66-75.
133. Shaker OG, Hammam OA, El Leithy TR, El Ganzoury H, Wishahi MM, Mikhailidis DP (2011).
Molecular
markers and bladder carcinoma: Schistosomal and non-schistosomal. Clinical Biochemistry, 44
(2-3): 237-44.
134. Roshdy M, Hammam O, Wishahi M and Nour H (2011).
Expression of transforming growth factor beta-1 protein and its
receptor in tissue of patients with bladder cancer associated with
scistosomiasis or not associated. Current Urology, 5: 33-40.
135. Hammam O, El Badrawy N, El Ghanam M, Hassan
M, Safwat W, Anas A (2011). Micro vascular density MVD-CD34 and VEGF
expression in the liver of patients with chronic hepatitis, cirrhosis and
hepatocellular carcinoma. Journal of American Science; 7 (6): 808-815
136. El-Lakkany NM, El-Maadawy WH, Ain-Shoka AA,
Badawy AA, Hammam OA and Ebeid FA (2011). Potential antifibrotic
effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and
chronic experimental liver fibrosis induced by Schistosoma mansoni. Clinical
and Experimental Pharmacology and Physiology, 38 (10): 695.
137.
Ma N, Thanan R, Kobayashi H, Hammam O, Wishahi M, El Leithy T, Hiraku Y, Amro E, Oikawa S, Ohnishi S, Murata M and Kawanishi S (2011). Nitrative DNA
damage and Oct3/4 expression in urinary bladder cancer with Schistosoma
haematobium infection. Biochemical
and Biophysical Research Communicat, 414
(2): 344.
138.
El-Lakkany, Seif
El-Din SH, Sabra AN, and Hammam OA (2011). Pharmacodynamics of mefloquine and
praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma
mansoni. Memorias
do Instituto Oswaldo Cruz, 106(7):
814.
139. Hammam O, Zahran M, Mahmoud O, Aly
S, Hosny K, Helmy A and Anas A (2012). The Role of fas/fas
ligand system in the pathogenesis of liver cirrhosis and hepatocellular
carcinoma. Hepatitis Monthly; 12 (11): 6132.
140. Elmansy H, Kotb A, Hammam O, Abdelraouf H, Salem H, Onsi M and Elleithy T (2012). Prognostic impact of apoptosis marker Fas
(CD95) and its ligand (FasL) on bladder cancer in Egypt: Study of the effect of
schistosomiasis. E Cancer Medical Science; 6: 278.
141. El-Ansary M, Abdel-Aziz I, Mogawer S, Abdel-Hamid S, Hammam O,
Teaema S and Wahdan M (2012). Phase II trial: Undifferentiated versus differentiated autologous
mesenchymal stem cells transplantation in Egyptian patients with HCV induced
liver cirrhosis.
Stem Cell Rev and Rep, 8 (3): 972-981.
142. El-Lakkany NM, Hammam OA, El-Maadawy WH, Badawy AA, Ain-Shoka
AA and Ebeid FA (2012). Anti-inflammatory/anti-fibrotic effects of the hepatoprotective
silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced
liver fibrosis. Parasit Vectors; 11; 5: 9.
143. Thanan R, Murata M, Ma N, Hammam O, Wishahi M,
El Leithy T, Hiraku Y, Oikawa S and Kawanishi S (2012). Nuclear
localization of COX-2 in relation to the expression of stemness markers in
urinary bladder cancer. Mediators Inflammation, 165879.
[PubMed]. (doi: 10.1155/2012/165879. Epub Accepted Apr 10).
144. Shaker OG, Hammam OA and Wishahi MM (2012). Is there a correlation between HPV and
urinary bladder carcinoma?. Biomedicine and Pharmacotherapy. Accepted for
Publication on Dec 7. {PubMed}.
145. Hedya MS, Nasr MM, Ezzat H, Hamdy
HM, Hassan AM and Hammam O (2012). Histopathological
findings in appendectomy specimens: A retrospective clinicopathological
analysis. J Egypt Soc Parasitol, 42 (1): 157-64.
146. El Ghanam M, El Badrawy N, Hammam O, Hassan M and Anas A (2012).
Tissue expression of PCNA and Caspase3 in the liver in patients with chronic
hepatitis, cirrhosis and hepatocellular carcinoma. Life Science Journal, 9 (2): 1083-1087.
147.Mahmoud M, Hammam O and El-Sherbiny
M (2012). Immunohistological and
pharmacological studies of anti-inflammatory drugs in experimental
schistosomiasis. Accepted for Publication in African Journal of Pharmacy and
Pharmacology (AJPP). October 14, 2012 (Google).
148. El-Raay A, Marcelain P, Akl M, Paradie V, Atta R and
El-Ghannam M (2012). Insulin Resistance: A
major factor associated with significant liver fibrosis in Egyptian patients
with Genotype 4 chronic hepatitis C. Accepted in European Journal of Gastroenterology and
Hepatology on December 2012.
149. Attia YM, Elalkamy EF, Hammam OA, Mahmoud SS
and El-Khatib AS (2013). Telmisartan, an AT1
receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced
experimentally by Schistosoma mansoni infection. Parasites &
Vectors, 6: 199.
150.
Hammam O,
Mahmoud, O, Zahran M, Sayed A, Salama R, Hosny K and Farghly A (2013). A possible role for TNF-α in
coordinating inflammation and angiogenesis in chronic liver disease and
hepatocellular carcinoma. Gastrointestinal
Cancer Research: GCR, 6(4): 107-114.
151.
Seif El-Din SH, Sabra AA, Hammam OA and El-Lakkany NM (2013). Effect of ketoconazole, a cytochrome
P450 inhibitor, on the efficacy of quinine and halofantrine against Schistosoma
mansoni in Mice. The Korean
Journal of Parasitology, 51(2): 165-175.
152.
Abdel Haleem H, Zayed N, Abdel
Hafez H, Fouad A, Akl M, Hassan M, Hammam O, Morsy A, Saleh A, Seyam M, Zakaria Z and Zakaria S (2013).
Evaluation of the diagnostic value of serum and tissue apoptotic cytokeratin-18
in patients with chronic hepatitis C. Arab Journal
of Gastroenterology, 14 (2): 68.
153. Shaker O, Hammam O, Wishahi M and Roshdi M (2013). TGF-B1 pathway as biological marker of bladder
carcinoma schistosomal and non-schistosomal. Urologic Oncology: Seminars and Original Invest, 31(3): 372.
This comment has been removed by a blog administrator.
ReplyDelete